Table 2.
Results of the antimicrobial sensitivity of the isolates in the present study.
| Antimicrobial agent | MRSA (n=204) | MSSA (n=1175) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sensitivity (%) | Resistance (%) | MIC50 (μg/mL) | MIC90 (μg/mL) | MICrange (μg/mL) | Sensitivity (%) | Resistance (%) | MIC50 (μg/mL) | MIC90 (μg/mL) | MICrange (μg/mL) | |
| CEFAZO | 88.24 | 11.76 | 2 | >8 | 1~>8 | 99.15 | 0.85 | 1 | 1 | ≤0.25~>8 |
| CEFTRI | 49.51 | 50.49 | 16 | 64 | 6~>256 | 98.21 | 1.79 | 4 | 4 | ≤0.25~>16 |
| CEFURO | 46.08 | 10.78 | 8 | 32 | ≤4~>64 | 98.38 | 0.34 | ≤4 | ≤4 | ≤4~64 |
| CHLORA | 47.55 | 11.27 | 16 | >32 | ≤4~>32 | 55.74 | 7.32 | 8 | 16 | ≤4~>32 |
| CIPROF | 93.14 | 4.41 | ≤0.25 | 0.5 | ≤0.25~>4 | 92.00 | 1.53 | ≤0.25 | 0.5 | ≤0.25~>4 |
| CLINDA | 31.86 | 66.18 | >16 | >16 | ≤0.5~>16 | 47.40 | 49.96 | 2 | >16 | ≤0.5~>16 |
| ERYTH | 5.39 | 87.74 | >64 | >64 | 0.032>64 | 14.98 | 75.91 | >64 | >64 | 0.125>64 |
| FUSIDA | 97.06 | 2.94 | ≤0.125 | 0.25 | ≤0.125~>2 | 95.15 | 4.85 | 0.25 | 0.25 | ≤0.125~>2 |
| GENTAM | 97.55 | 1.47 | ≤0.125 | 0.25 | ≤0.125~>32 | 96.60 | 1.79 | ≤0.125 | 0.25 | ≤0.125~>32 |
| MUPIRO | 96.57 | 2.45 | ≤0.125 | 0.25 | ≤0.125~>512 | 98.13 | 1.19 | ≤0.125 | ≤0.125 | 0.06~>512 |
| PENICI | 0 | 100 | >8 | >8 | 0.12~>8 | 6.81 | 93.19 | 8 | >8 | ≤0.125~>8 |
| RIFAMP | 93.63 | 0.49 | ≤0.015 | 1.5 | ≤0.015~4 | 97.19 | 0.43 | ≤0.015 | 0.5 | 0.002~>32 |
| TETRA | 65.20 | 34.80 | ≤0.5 | 32 | ≤0.5~32 | 90.04 | 9.36 | ≤0.5 | 2 | ≤0.5~>32 |
| TRISUL | 99.51 | 0.49 | ≤0.125 | 1 | ≤0.125~8 | 99.32 | 0.68 | 0.5 | 1 | ≤0.125~16 |
| VANCOM | 100.00 | 0.00 | ≤0.5 | 1 | ≤0.5~2 | 100.00 | 0.00 | ≤0.5 | 1 | ≤0.5~2 |
CEFAZO, Cefazolin; CEFTRI, cefatriaxone; CEFURO, Cefuroxime; CHLORA, Chloramphenicol; CIPROF, Ciprofloxacin; CLINDA, Clindamycin; ERYTH, Erythromycin; FUSIDA, Fusidic acid; GENTAM, Gentamicin; MUPIRO, Mupirocin; PENICI, Penicillin; RIFAMP, Rifampin; TETRA, Tetracycline; TRISUL, Trimethoprim-sulfamethoxazole; VANCOM, Vancomycin.